435 (Acamprosate Calcium Delayed-Release 333 mg)
Pill with imprint 435 is White, Round and has been identified as Acamprosate Calcium Delayed-Release 333 mg. It is supplied by Glenmark Generics Inc., USA.
Acamprosate is used in the treatment of alcohol dependence and belongs to the drug class drugs used in alcohol dependence. Risk cannot be ruled out during pregnancy. Acamprosate 333 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 435
Acamprosate Calcium Delayed-Release
- Imprint
- 435
- Strength
- 333 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Drugs used in alcohol dependence
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Generics Inc., USA
- Inactive Ingredients
-
silicon dioxide,
crospovidone,
methacrylic acid - ethyl acrylate copolymer (1:1) type a,
magnesium stearate,
microcrystalline cellulose,
propylene glycol,
sodium starch glycolate type A potato,
magnesium silicate,
povidone k30
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68462-0435 | Glenmark Pharmaceuticals Inc. |
| 10135-0636 | Marlex Pharmaceuticals Inc. |
Related Images for "435"
More about acamprosate
- Side effects
- Dosage information
- During pregnancy
- Reviews (261)
- Drug images
- Pricing & coupons
- En español
- Drug class: drugs used in alcohol dependence
Patient resources
- Other brands
- Campral
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.